Reckitt Benckiser Group (LON:RKT) Sets New 1-Year Low at $1,747.00

Reckitt Benckiser Group plc (LON:RKT)’s share price reached a new 52-week low during trading on Thursday . The company traded as low as GBX 1,747 ($21.75) and last traded at GBX 4,137 ($51.50), with a volume of 4760313 shares. The stock had previously closed at GBX 4,110 ($51.16).

Wall Street Analyst Weigh In

Separately, HSBC reaffirmed a “hold” rating on shares of Reckitt Benckiser Group in a report on Thursday.

Reckitt Benckiser Group Price Performance

The company has a quick ratio of 0.46, a current ratio of 0.64 and a debt-to-equity ratio of 100.80. The stock has a market capitalization of £29.32 billion, a price-to-earnings ratio of 1,828.63, a P/E/G ratio of 3.76 and a beta of 0.07. The business’s 50 day simple moving average is GBX 4,928.11 and its 200-day simple moving average is GBX 5,345.05.

Reckitt Benckiser Group Increases Dividend

The company also recently declared a dividend, which will be paid on Friday, May 24th. Investors of record on Thursday, April 11th will be given a dividend of GBX 115.90 ($1.44) per share. This is a positive change from Reckitt Benckiser Group’s previous dividend of $76.60. The ex-dividend date is Thursday, April 11th. This represents a dividend yield of 1.99%. Reckitt Benckiser Group’s dividend payout ratio (DPR) is currently 8,502.20%.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; vaginal care routine products; sore throat medications; and hair removal products under the Clearasil, Dettol, Durex, Gaviscon, Nurofen, Mucinex, Queen V, Strepsils, and Veet brands.